Nicotine therapeutic benefits: Difference between revisions
Jump to navigation
Jump to search
(formatting) |
(formatting) |
||
| Line 423: | Line 423: | ||
<br> | <br> | ||
= | ='''Cognitive / IQ'''= <!--T:88--> | ||
===2020 [https://www.sciencedirect.com/science/article/abs/pii/S0306452220304723?via%3Dihub Effects of Nicotine on Task Switching and Distraction in Non-smokers. An fMRI Study]=== <!--T:89--> | ===2020 [https://www.sciencedirect.com/science/article/abs/pii/S0306452220304723?via%3Dihub Effects of Nicotine on Task Switching and Distraction in Non-smokers. An fMRI Study]=== <!--T:89--> | ||
| Line 434: | Line 433: | ||
*Acknowledgements: This work was supported by a grant from the German Research Foundation DFG TH766/8-1. | *Acknowledgements: This work was supported by a grant from the German Research Foundation DFG TH766/8-1. | ||
*Key words: nicotine, cholinergic, cognitive control, distraction, task switching, neuroimaging | *Key words: nicotine, cholinergic, cognitive control, distraction, task switching, neuroimaging | ||
===2018 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018192/ Cognitive Effects of Nicotine: Recent Progress]=== <!--T:91--> | ===2018 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018192/ Cognitive Effects of Nicotine: Recent Progress]=== <!--T:91--> | ||
| Line 443: | Line 440: | ||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018192/pdf/CN-16-403.pdf PDF Version] | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018192/pdf/CN-16-403.pdf PDF Version] | ||
*Citation: Valentine G, Sofuoglu M. Cognitive Effects of Nicotine: Recent Progress. Curr Neuropharmacol. 2018;16(4):403-414. doi: 10.2174/1570159X15666171103152136. PMID: 29110618; PMCID: PMC6018192. | *Citation: Valentine G, Sofuoglu M. Cognitive Effects of Nicotine: Recent Progress. Curr Neuropharmacol. 2018;16(4):403-414. doi: 10.2174/1570159X15666171103152136. PMID: 29110618; PMCID: PMC6018192. | ||
===2016: [https://truthinitiative.org/sites/default/files/media/files/2019/08/ReThinking-Nicotine_0.pdf Re-thinking nicotine and its effects]=== | ===2016: [https://truthinitiative.org/sites/default/files/media/files/2019/08/ReThinking-Nicotine_0.pdf Re-thinking nicotine and its effects]=== | ||
| Line 449: | Line 445: | ||
*Some subgroups, such as those with an underlying vulnerability to mental health or medical conditions, may benefit, more or less, from the use of nicotine, when compared with the general population. | *Some subgroups, such as those with an underlying vulnerability to mental health or medical conditions, may benefit, more or less, from the use of nicotine, when compared with the general population. | ||
*Truth Initiative / Schroeder Institute: Raymond Niaura, PhD. - This paper was also reviewed by content area experts whose feedback was included: Drs. Neal Benowitz, Peter Shields, Dorothy Hatsukami, and Ken Warner | *Truth Initiative / Schroeder Institute: Raymond Niaura, PhD. - This paper was also reviewed by content area experts whose feedback was included: Drs. Neal Benowitz, Peter Shields, Dorothy Hatsukami, and Ken Warner | ||
===2012: [https://pubmed.ncbi.nlm.nih.gov/22503574/ The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition]=== <!--T:93--> | ===2012: [https://pubmed.ncbi.nlm.nih.gov/22503574/ The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition]=== <!--T:93--> | ||
| Line 460: | Line 455: | ||
*Citation: Dawkins, L., Turner, J., Hasna, S., & Soar, K. (2012). The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition. Addictive Behaviors, 37(8), 970–973. doi:10.1016/j.addbeh.2012.03.004 | *Citation: Dawkins, L., Turner, J., Hasna, S., & Soar, K. (2012). The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition. Addictive Behaviors, 37(8), 970–973. doi:10.1016/j.addbeh.2012.03.004 | ||
*Electronic Cigarette Company (TECC) supplied the e-cigarettes and cartridges for this study. TECC had no involvement in the design or conduct of the study. | *Electronic Cigarette Company (TECC) supplied the e-cigarettes and cartridges for this study. TECC had no involvement in the design or conduct of the study. | ||
===2003 [https://www.nature.com/articles/1300202 Psychoactive Drugs and Pilot Performance: A Comparison of Nicotine, Donepezil, and Alcohol Effects]=== <!--T:95--> | ===2003 [https://www.nature.com/articles/1300202 Psychoactive Drugs and Pilot Performance: A Comparison of Nicotine, Donepezil, and Alcohol Effects]=== <!--T:95--> | ||
| Line 470: | Line 464: | ||
*Acknowledgements: This research was supported in part by NIMH Grant 40041; NIA Grant AG17824; the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC); the Alcohol Beverage Medical Research Foundation; the Swiss Foundation for Alcohol Research; the Swiss National Science Foundation; and the Medical Research Service of the Department of Veterans Affairs. | *Acknowledgements: This research was supported in part by NIMH Grant 40041; NIA Grant AG17824; the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC); the Alcohol Beverage Medical Research Foundation; the Swiss Foundation for Alcohol Research; the Swiss National Science Foundation; and the Medical Research Service of the Department of Veterans Affairs. | ||
*Keywords: cholinergic agents, ethanol, cognition, psychomotor performance, psychopharmacology, aerospace medicine | *Keywords: cholinergic agents, ethanol, cognition, psychomotor performance, psychopharmacology, aerospace medicine | ||
===1996 [https://link.springer.com/article/10.1007/BF02805972 Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers]=== | ===1996 [https://link.springer.com/article/10.1007/BF02805972 Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers]=== | ||
*These results are consistent with other recent research suggesting a primary effect of nicotine in enhancing cognitive performance. | *These results are consistent with other recent research suggesting a primary effect of nicotine in enhancing cognitive performance. | ||
*Citation: Foulds, J., Stapleton, J., Swettenham, J. et al. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology 127, 31–38 (1996). https://doi.org/10.1007/BF02805972 | *Citation: Foulds, J., Stapleton, J., Swettenham, J. et al. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology 127, 31–38 (1996). https://doi.org/10.1007/BF02805972 | ||
===1994 [https://link.springer.com/article/10.1007/BF02245346 Smoking and raven IQ]=== <!--T:97--> | ===1994 [https://link.springer.com/article/10.1007/BF02245346 Smoking and raven IQ]=== <!--T:97--> | ||
| Line 485: | Line 477: | ||
*Citation: Stough, C., Mangan, G., Bates, T. et al. Smoking and raven IQ. Psychopharmacology 116, 382–384 (1994). doi: 10.1007/BF02245346 | *Citation: Stough, C., Mangan, G., Bates, T. et al. Smoking and raven IQ. Psychopharmacology 116, 382–384 (1994). doi: 10.1007/BF02245346 | ||
*Key words: Intelligence, APM, Nicotine, Smoking Cholinergic system | *Key words: Intelligence, APM, Nicotine, Smoking Cholinergic system | ||
===1992 [https://pubmed.ncbi.nlm.nih.gov/1579636/ Nicotine as a cognitive enhancer]=== <!--T:99--> | ===1992 [https://pubmed.ncbi.nlm.nih.gov/1579636/ Nicotine as a cognitive enhancer]=== <!--T:99--> | ||